These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19694181)

  • 1. Development and physical characterization of chloramphenicol loaded biodegradable nanoparticles for prolonged release.
    Mandal B; Halder KK; Dey SK; Bhoumik M; Debnath MC; Ghosh LK
    Pharmazie; 2009 Jul; 64(7):445-9. PubMed ID: 19694181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of azithromycin-PLGA nanoparticles: physicochemical characterization and antibacterial effect against Salmonella typhi.
    Mohammadi G; Valizadeh H; Barzegar-Jalali M; Lotfipour F; Adibkia K; Milani M; Azhdarzadeh M; Kiafar F; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Oct; 80(1):34-9. PubMed ID: 20558048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
    Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral.
    Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN
    J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
    Misra R; Acharya S; Dilnawaz F; Sahoo SK
    Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Estradiol biodegradable microspheres: effect of formulation parameters on encapsulation efficiency and in vitro release.
    Zaghloul AA
    Pharmazie; 2006 Sep; 61(9):775-9. PubMed ID: 17020154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies.
    Halder KK; Mandal B; Debnath MC; Bera H; Ghosh LK; Gupta BK
    J Drug Target; 2008 May; 16(4):311-20. PubMed ID: 18446610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy.
    Zhang HZ; Gao FP; Liu LR; Li XM; Zhou ZM; Yang XD; Zhang QQ
    Colloids Surf B Biointerfaces; 2009 Jun; 71(1):19-26. PubMed ID: 19186037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles.
    Kim BS; Kim CS; Lee KM
    Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro characterization of slow release testosterone nanocapsules in alginates.
    Bhowmik BB; Sa B; Mukherjee A
    Acta Pharm; 2006 Dec; 56(4):417-29. PubMed ID: 19839134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST; Devi SG; KV S
    AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
    Imbuluzqueta E; Elizondo E; Gamazo C; Moreno-Calvo E; Veciana J; Ventosa N; Blanco-Prieto MJ
    Acta Biomater; 2011 Apr; 7(4):1599-608. PubMed ID: 21115143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.